(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cefixime: Powder for oral suspension (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CEFIXIME (sef IX eem) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information

Cefixime 100mg/5ml Powder for Suspension

NDC: 658620751
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tonsillitis, Urethritis, Gonorrhea, Pharyngitis, Urinary Tract Infection (UTI), Otitis Media, Bronchitis, Cervicitis

Sometimes used for but not FDA approved for the following conditions:
Typhoid Fever, Sinusitis

Storage Information
Discard any unused reconstituted product after 14 days
Reconstituted product may be stored in refrigerator (36 to 46 degrees F) or at room temperature (up to 77 degrees F)
Store unreconstituted product at 68 to 77 degrees F
Cefixime 100mg/5ml Powder for Suspension

Reported Side Effects for Cefixime 100mg/5ml Powder for Suspension

Vaginal Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hives Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Low White Blood Cells Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low Prothrombin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.0-16.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cefixime

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5